TXG
- 10x Genomics, Inc.
()
Overview
Company Summary
10x Genomics, Inc. is a biotechnology company that focuses on developing and commercializing advanced genomics technologies. The company's primary aim is to enable researchers to investigate the complexities of biology and human health by providing innovative tools and solutions.
10x Genomics specializes in developing single-cell and spatial genomics solutions. Their flagship product is the Chromium System, a genomic platform that allows scientists to analyze the genomic information of individual cells simultaneously in a high-throughput manner. By providing a detailed view of gene expression, DNA sequencing, and other genomic features at the single-cell level, this technology offers valuable insights into cellular heterogeneity and various biological processes.
The company also offers innovative spatial transcriptomics solutions, such as the Visium Spatial Gene Expression Solution. This technology enables the mapping of gene expression in intact tissue samples, allowing researchers to analyze the spatial organization of cells and better understand tissue biology.
By leveraging their expertise in genomics and developing cutting-edge technologies, 10x Genomics aims to empower scientists and accelerate discoveries in the fields of cancer research, immunology, neuroscience, and many other areas of biomedicine. They collaborate with academic institutions, pharmaceutical companies, and research organizations to drive advancements in genomics research, biomarker discovery, and precision medicine.
Overall, 10x Genomics plays a crucial role in advancing our understanding of human biology, disease mechanisms, and therapeutic approaches by providing state-of-the-art genomics tools and solutions.